Aaron Wong

19PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersChemotherapyPharmacogenomicsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 27, 2025
Oxycodone/naloxone PR versus oxycodone PR in advanced cancer: A multi-centre randomised trial (ENhANCE trial).

Aaron K Wong, Anneke Grobler, Ruwani Mendis

|Jan 08, 2025
Challenges with cancer pain management: novel opioid shortages and cancer trials restrictions.

Aaron Bak Ong Wong, Benjamin Crock, Myles Wright

|Dec 04, 2024
Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?

Aaron K Wong, Sara Vogrin, Pal Klepstad

|Sep 10, 2024
Influence of <i>COMT</i> (rs4680) and <i>OPRM1</i> (rs1799971) on Cancer Pain, Opioid Dose, and Adverse Effects.

Aaron K Wong, Pal Klepstad, Andrew A Somogyi

|Jun 25, 2024
Opioid initiation timing and palliative care referrals in advanced cancer: retrospective study.

Aaron Kee Yee Wong, Dorothy Wang, Ian Gordon

Pageof 4